Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study

BACKGROUND: The clinical implications of potential interactions between proton pump inhibitors (PPIs) and clopidogrel have been debated for over a decade. OBJECTIVE: We assessed the association between combined clopidogrel–PPI treatment and the risk of recurrent myocardial infarction (MI) and three...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhat, Nawal, Birkett, Nicholas, Haddad, Nisrine, Fortin, Yannick, Momoli, Franco, Wen, Shi Wu, Wielgosz, Andreas, McNair, Doug S., Mattison, Donald R., Krewski, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392938/
https://www.ncbi.nlm.nih.gov/pubmed/32617885
http://dx.doi.org/10.1007/s40801-020-00204-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392938/
https://www.ncbi.nlm.nih.gov/pubmed/32617885
http://dx.doi.org/10.1007/s40801-020-00204-9

Ejemplares similares